Hodge's Court

Obsidian Therapeutics Inc, based in Cambridge, MA, is at the forefront of precision cell and gene therapy, utilizing its proprietary cytoDRIVE platform to engineer regulated therapeutic proteins. The company is dedicated to pioneering the next generation of engineered therapeutics to address critical patient needs. With a focus on innovative solutions, Obsidian is advancing its lead clinical program, OBX115, an engineered TIL cell therapy targeting advanced melanoma. The company’s commitment to collaboration and urgency drives its mission to improve patient outcomes through cutting-edge science and technology. Generated from the website

Aya Research Institute Inc is a research organization based in Cambridge, MA, specializing in cutting-edge scientific studies and data analysis. The company focuses on conducting research in various fields, providing valuable insights and contributing to advancements in knowledge and technology. Generated from their business information